Temporary downregulation of adaptor gene SH2B3 in cKIT-CD117+/CD133+/CD34+ HSC can be a therapeutic switch to improve downregulated stem cell response in ischemia, tissue repair, and myocardial infarction. This evidence concerns the gene PROM1 and myocardial infarction.